Does short term clarithromycin affect cardiovascular mortality in patients with stable coronary heart disease?
Short-term clarithromycin use in patients with stable coronary heart disease is associated with a safety signal of increased cardiovascular mortality.
Short term clarithromycin in patients with stable coronary heart disease may cause significantly higher cardiovascular mortality. The long term safety of clarithromycin in patients with stable ischaemic heart disease should be examined. Trial registration ClinicalTrials.gov NCT00121550.
Jespersen et al. (Thu,) studied this question.